GAMMA Investing LLC Buys 3,428 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

GAMMA Investing LLC increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 143.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,812 shares of the company’s stock after buying an additional 3,428 shares during the quarter. GAMMA Investing LLC’s holdings in Acadia Healthcare were worth $176,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Treasurer of the State of North Carolina raised its position in Acadia Healthcare by 0.6% in the 4th quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company’s stock valued at $1,586,000 after purchasing an additional 250 shares during the last quarter. Coldstream Capital Management Inc. raised its position in Acadia Healthcare by 4.9% in the 4th quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company’s stock valued at $257,000 after purchasing an additional 303 shares during the last quarter. Covestor Ltd raised its position in Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company’s stock valued at $58,000 after purchasing an additional 310 shares during the last quarter. Xponance Inc. raised its position in Acadia Healthcare by 5.9% in the 4th quarter. Xponance Inc. now owns 10,530 shares of the company’s stock valued at $418,000 after purchasing an additional 590 shares during the last quarter. Finally, Lindbrook Capital LLC raised its position in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after purchasing an additional 671 shares during the last quarter.

Acadia Healthcare Stock Up 3.1%

NASDAQ ACHC opened at $23.90 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.35 and a current ratio of 1.35. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41. The stock has a fifty day moving average of $23.01 and a 200-day moving average of $31.22. The stock has a market capitalization of $2.20 billion, a P/E ratio of 11.77, a price-to-earnings-growth ratio of 4.44 and a beta of 0.93.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.05. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The business had revenue of $770.51 million during the quarter, compared to analysts’ expectations of $769.90 million. During the same period in the previous year, the firm earned $0.84 earnings per share. The firm’s quarterly revenue was up .3% compared to the same quarter last year. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Ratings Changes

ACHC has been the subject of several research analyst reports. Guggenheim initiated coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price objective for the company. Wall Street Zen upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, May 22nd. Barclays cut their price objective on Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating for the company in a research report on Wednesday, May 14th. Mizuho lowered their target price on Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating for the company in a research note on Wednesday, May 14th. Finally, Stephens raised Acadia Healthcare to a “hold” rating in a research note on Monday, June 2nd. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $47.94.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.